Manage Your Liver
Q:

What is liver cirrhosis?

A:

Cirrhosis is a late stage of fibrosis of the liver. It is the result of long term damage to liver cells.
Fibrosis of the liver is excessive accumulation of scar tissue that results from ongoing inflammation and liver cell death. Each time your liver is injured, it tries to repair itself. In the process, scar tissue forms. As the scar tissue builds up, it becomes more difficult for the liver to function.

According to the U.S. Department of Health and Human Services, the main causes of cirrhosis are chronic hepatitis B or C, alcoholism and fatty liver disease.

 

Alcoholism is the leading cause of cirrhosis in the U.S. It develops in 10–20% of heavy drinkers.

alcoholic

The 5-year survival rate for cirrhosis patients who cease drinking is about 90%, compared with 70% of those who continue to drink.

 

Causes

The main causes of cirrhosis are:

  • Sustained excessive alcohol consumption
  • Chronic viral hepatitis B and C
  • Nonalcoholic fatty liver disease (NAFLD) / Nonalcoholic steatohepatitis (NASH)

 

Signs and Symptoms

  • Loss of appetite
  • Fatigue
  • Nausea
  • Easy bruising
  • Jaundice (yellowing of skin or whites of eyes)

 

Diagnosis

An ultrasound of the liver, a computed tomography (CT) scan or magnetic resonance imaging (MRI) can be used to check for liver damage. A liver biopsy will be needed to confirm the diagnosis.

 

Cirrhosis Liver Treatment

Currently, there is no cure for cirrhosis. Treatment of cirrhosis is limited and is mostly designed to prevent further damage and manage the symptoms and any complications. Treating the underlying conditions that may be the cause can also slow the progression of cirrhosis.

In more advanced stages of cirrhosis, the scarring may cause liver failure (the liver stops functioning). In this case, the only treatment option is a liver transplant.

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
CirrhosisLiver Cirrhosis
Related Questions
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
A:
In our last post, we brought up the recent findings on extreme liver cancer growth after successful DAA treatment. We are talking about liver cancer of a few centimetres developed within weeks of successful Hep C treatment. These findings are also observed in patients of Gastroenterology. Dr. Roushdi Khalf allah sai
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us